Diana Mckenzie - 17 Feb 2023 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Director
Signature
/s/ Timothy Bensley, as Attorney-in-Fact
Issuer symbol
AGL
Transactions as of
17 Feb 2023
Net transactions value
$0
Form type
4
Filing time
22 Feb 2023, 16:20:06 UTC
Previous filing
18 Jan 2023
Next filing
02 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Award $0 +1,078 $0.000000 1,078 17 Feb 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Rights to Buy) Award $0 +11,104 $0.000000 11,104 17 Feb 2023 Common Stock 11,104 $22.79 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units that vest in full on February 17, 2024, subject to continued service as a director.
F2 Options that vest in three equal installments on each anniversary of February 17, 2023, subject to continued service as a director.